Emilio Francesco Giunta

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Cancers

Future oncology (London, England)

Expert opinion on drug metabolism & toxicology

International journal of molecular sciences

Università degli studi della Campania "Luigi Vanvitelli"

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli studi della Campania "Luigi Vanvitelli" Nov 01 2016

Italy

Oncologist in training :: UOC Oncoematologia

Publications

Emilio Francesco Giunta, Lorenzo Gasperoni, Ugo De Giorgi
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better? Future oncology (London, England) (2024)
Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Emilio Francesco Giunta, Andrea Messori, Vera Damuzzo
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy? Cancers 16 (13) (2024)
Emilio Francesco Giunta, Lorenzo Gasperoni, Ugo De Giorgi
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better? Future oncology (London, England) 20 (4) (2024)
Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Emilio Francesco Giunta, Andrea Messori, Vera Damuzzo
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy? Cancers 16 (13) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology (2024)
Emilio Francesco Giunta, Lorenzo Gasperoni, Ugo De Giorgi
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better? Future oncology (London, England) 20 (4) (2024)
Emilio Francesco Giunta, Lorenzo Gasperoni, Ugo De Giorgi
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better? Future oncology (London, England) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Emilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, Amelia Altavilla, Virginia Rossetti, Irene Marini, Monica Celli, Chiara Casadei, Cristian Lolli, Giuseppe Schepisi, Sara Bleve, Nicole Brighi, Maria Concetta Cursano, Giovanni Paganelli, Federica Matteucci, Ugo De Giorgi
Correlation of [ 68 Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients. European journal of nuclear medicine and molecular imaging (2024)
Emilio Francesco Giunta, Lorenzo Gasperoni, Ugo De Giorgi
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better? Future oncology (London, England) 20 (4) (2024)
Maria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, Chiara Casadei, Alessandra Virga, Paola Ulivi, Sara Bleve, Nicole Brighi, Giorgia Ravaglia, Francesco Pantano, Vincenza Conteduca, Daniele Santini, Ugo De Giorgi
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. International journal of molecular sciences 24 (15) (2023)
Anju Jose, Maria Grazia Bavetta, Erika Martinelli, Fabrizio Bronte, Emilio Francesco Giunta, Kanjoormana Aryan Manu
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. Journal of oncology 2022 (2022)
Anju Jose, Maria Grazia Bavetta, Erika Martinelli, Fabrizio Bronte, Emilio Francesco Giunta, Kanjoormana Aryan Manu
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. Journal of oncology 2022 (2022)
Margaret Ottaviano, Emilio Francesco Giunta, Laura Marandino, Marianna Tortora, Laura Attademo, Davide Bosso, Cinzia Cardalesi, Antonietta Fabbrocini, Mario Rosanova, Antonia Silvestri, Liliana Montella, Pasquale Tammaro, Ester Marra, Claudia Trojaniello, Maria Grazia Vitale, Ester Simeone, Teresa Troiani, Bruno Daniele, Paolo Antonio Ascierto
Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas. Biomedicines 10 (1) (2022)
Emilio Francesco Giunta, Vincenzo De Falco, Pietro Paolo Vitiello, Luigi Pio Guerrera, Gabriella Suarato, Rossella Napolitano, Alessandra Perrone, Giuseppe Argenziano, Renato Franco, Michele Caraglia, Erika Martinelli, Davide Ciardiello, Fortunato Ciardiello, Stefania Napolitano, Teresa Troiani
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR. Cancers 14 (13) (2022)
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo, Bruno Daniele
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 14 (24) (2022)
Gianluca Arrichiello, Valeria Nacca, Fernando Paragliola, Emilio Francesco Giunta
Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, Lucia Fratino, Sara Elena Rebuzzi, Sebastiano Buti, Marco Maruzzo, Ugo De Giorgi, Veronica Murianni, Marika Cinausero, Helga Lipari, Teresa Gamba, Orazio Caffo, Davide Bimbatti, Arianna Dri, Alessandra Mosca, Paola Ermacora, Francesca Vignani, Aichi Msaki, Barbara Bonifacio, Valentina Lombardo, Vincenza Conteduca, Giuseppe Fornarini, Pasquale Rescigno
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network. Current oncology (Toronto, Ont.) 29 (10) (2022)
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo, Bruno Daniele
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 14 (24) (2022)
Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, Ricardo Pereira Mestre, Laura Marandino, Marianna Tortora, Vittorio Riccio, Sara Parola, Milena Casula, Panagiotis Paliogiannis, Antonio Cossu, Ursula Maria Vogl, Davide Bosso, Mario Rosanova, Brunello Mazzola, Bruno Daniele, Giuseppe Palmieri, Giovannella Palmieri
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something? International journal of molecular sciences 22 (13) (2021)
Teresa Troiani, Stefania Napolitano, Gabriella Brancaccio, Valentina Belli, Annarita Nappi, Caterina Miro, Domenico Salvatore, Monica Dentice, Michele Caraglia, Renato Franco, Emilio Francesco Giunta, Vincenzo De Falco, Davide Ciardiello, Fortunato Ciardiello, Giuseppe Argenziano
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results. Journal of personalized medicine 11 (3) (2021)
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, Davide Bosso, Laura Attademo, Cinzia Cardalesi, Anna Diana, Antonietta Fabbrocini, Teresa Fabozzi, Pasqualina Giordano, Margaret Ottaviano, Mario Rosanova, Antonia Silvestri, Piera Federico, Bruno Daniele
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them. Journal of clinical medicine 10 (8) (2021)
Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, Alessandra Damassi, Emilio Francesco Giunta, Filippo Fraggetta, Ugo De Giorgi, Richard Cathomas, Pasquale Rescigno, Matteo Brunelli, Giuseppe Fornarini
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence. Cancers 13 (21) (2021)
Emilio Francesco Giunta, Laura Annaratone, Enrico Bollito, Francesco Porpiglia, Matteo Cereda, Giuseppe Luigi Banna, Alessandra Mosca, Caterina Marchio, Pasquale Rescigno
Molecular Characterization of Prostate Cancers in the Precision Medicine Era. Cancers 13 (19) (2021)
Margaret Ottaviano, Emilio Francesco Giunta, Marianna Tortora, Marcello Curvietto, Laura Attademo, Davide Bosso, Cinzia Cardalesi, Mario Rosanova, Pietro De Placido, Erica Pietroluongo, Vittorio Riccio, Brigitta Mucci, Sara Parola, Maria Grazia Vitale, Giovannella Palmieri, Bruno Daniele, Ester Simeone, null On Behalf Of Scito Youth
BRAF Gene and Melanoma: Back to the Future. International journal of molecular sciences 22 (7) (2021)
Nicola Personeni, Valeria Smiroldo, Emilio Francesco Giunta, Maria Giuseppina Prete, Lorenza Rimassa, Giacomo Bregni, Francesco Sclafani
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives. Cancers 13 (18) (2021)
Piera Federico, Emilio Francesco Giunta, Annalisa Pappalardo, Andrea Tufo, Gianpaolo Marte, Laura Attademo, Antonietta Fabbrocini, Angelica Petrillo, Bruno Daniele
How to Treat Hepatocellular Carcinoma in Elderly Patients. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Emilio Francesco Giunta, Gianluca Arrichiello, Marcello Curvietto, Annalisa Pappalardo, Davide Bosso, Mario Rosanova, Anna Diana, Pasqualina Giordano, Angelica Petrillo, Piera Federico, Teresa Fabozzi, Sara Parola, Vittorio Riccio, Brigitta Mucci, Vito Vanella, Lucia Festino, Bruno Daniele, Paolo Antonio Ascierto, Margaret Ottaviano, null On Behalf Of Scito Youth
Epigenetic Regulation in Melanoma: Facts and Hopes. Cells 10 (8) (2021)
Emilio Francesco Giunta, Vincenzo De Falco, Stefania Napolitano, Giuseppe Argenziano, Gabriella Brancaccio, Elvira Moscarella, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani
Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations. Therapeutic advances in medical oncology 12 (2020)
Raimondo Di Liello, Flora Cimmino, Soraya Simón, Emilio Francesco Giunta, Vincenzo De Falco, Paloma Martín-Martorell
Role of liquid biopsy for thoracic cancers immunotherapy. Exploration of targeted anti-tumor therapy 1 (3) (2020)

Emilio Francesco Giunta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emilio Francesco Giunta